Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is -11.33% vs 32.28% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -96.51% vs 1,463.67% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is -63.19% vs 779.72% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is 450.00% vs -33.33% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
Compare Quarterly Results Of Wakamoto Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -11.33% vs 32.28% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 30.96% vs -7.87% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -96.51% vs 1,463.67% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -85.41% vs -73.42% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -63.19% vs 779.72% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 6,840.74% vs -102.54% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 450.00% vs -33.33% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 266.67% vs 200.00% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






